Neumora Therapeutics logo

Neumora Therapeutics Share Price Today

(NASDAQ: NMRA)

Neumora Therapeutics share price is $1.43 & ₹124.37 as on 6 Mar 2025, 2.30 'hrs' IST

$1.43

0.02

(1.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Neumora Therapeutics share price in Dollar and Rupees. Guide to invest in Neumora Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neumora Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Neumora Therapeutics share price movements

  • Today's Low: $1.38
    Today's High: $1.45

    Day's Volatility :5.17%

  • 52 Weeks Low: $1.35
    52 Weeks High: $21.00

    52 Weeks Volatility :93.57%

Neumora Therapeutics (NMRA) Returns

PeriodNeumora Therapeutics, Inc.Index (Russel 2000)
3 Months
-85.2%
0.0%
6 Months
-86.75%
0.0%
1 Year
-92.23%
0.0%
3 Years
-91.2%
-11.6%

Neumora Therapeutics (NMRA) Key Statistics

in dollars & INR

Previous Close
$1.41
Open
$1.41
Today's High
$1.45
Today's Low
$1.375
Market Capitalization
$228.4M
Today's Volume
$1.2M
52 Week High
$21.0
52 Week Low
$1.35
Revenue TTM
$0.0
EBITDA
$-262.8M
Earnings Per Share (EPS)
$-1.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-64.48%

How to invest in Neumora Therapeutics Stock (NMRA) from India?

It is very easy for Indian residents to invest directly in Neumora Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neumora Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neumora Therapeutics or NMRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neumora Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neumora Therapeutics shares which would translate to 0.608 fractional shares of Neumora Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neumora Therapeutics, in just a few clicks!

Returns in Neumora Therapeutics (NMRA) for Indian investors in Rupees

The Neumora Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neumora Therapeutics investment value today

Current value as on today

₹12,721

Returns

₹87,279

(-87.28%)

Returns from Neumora Therapeutics Stock

₹92,228 (-92.23%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Neumora Therapeutics (NMRA)

-62.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Neumora Therapeutics Shares from India has dropped by -62.0% over the past 30 days, indicating reduced transactional activity.

-84%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Neumora Therapeutics Stock from India on INDmoney has decreased by -84% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Neumora Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Neumora Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Neumora Therapeutics Stock (NMRA)

What analysts predicted

Upside of 555.32%

Target:

$9.37

Current:

$1.43

Insights on Neumora Therapeutics Stock (Ticker Symbol: NMRA)

  • Price Movement

    In the last 3 months, NMRA stock has moved down by -86.1%
  • NMRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 158.7%

Neumora Therapeutics Technicals Summary

Sell

Neutral

Buy

Neumora Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Neumora Therapeutics (NMRA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neumora Therapeutics, Inc. logo
-25.13%
-86.75%
-92.23%
-91.2%
-91.2%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neumora Therapeutics, Inc. logo
NA
NA
NA
-1.61
-0.64
-0.4
NA
1.78
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neumora Therapeutics, Inc. logo
Buy
$228.4M
-91.2%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Neumora Therapeutics

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Organization
Neumora Therapeutics
Employees
109
CEO
Mr. Jason G. Duncan J.D.
Industry
Miscellaneous

Management People of Neumora Therapeutics

NameTitle
Mr. Jason G. Duncan J.D.
Chief Legal Officer
Dr. Robert Lenz M.D., Ph.D.
Head of Research & Development
Dr. Joshua Pinto Ph.D.
President
Mr. Michael Lee Milligan
CFO & Principal Accounting Officer
Dr. Daljit Singh Aurora Pharm.D.
Chief Operationg and development officer
Dr. Rajesh Manchanda Ph.D.
Chief Technical Operations Officer
Dr. Nicholas Brandon Ph.D.
Chief Scientific Officer
Ms. Amy Sullivan
Chief Human Resources Officer
Ms. Lori Houle
Chief Quality Officer
Dr. Maryjo Chamberlain-Tharp Ph.D.
Chief Business Officer

Important FAQs about investing in NMRA Stock from India :

What is Neumora Therapeutics share price today?

Neumora Therapeutics share price today stands at $1.43, Open: $1.41 ; Previous Close: $1.41 ; High: $1.45 ; Low: $1.38 ; 52 Week High: $21.00 ; 52 Week Low: $1.35.

The stock opens at $1.41, after a previous close of $1.41. The stock reached a daily high of $1.45 and a low of $1.38, with a 52-week high of $21.00 and a 52-week low of $1.35.

Can Indians buy Neumora Therapeutics shares?

Yes, Indians can invest in the Neumora Therapeutics (NMRA) from India.

With INDmoney, you can buy Neumora Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neumora Therapeutics at zero transaction cost.

How can I buy Neumora Therapeutics shares from India?

It is very easy to buy Neumora Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neumora Therapeutics (NMRA) be purchased?

Yes, you can buy fractional shares of Neumora Therapeutics with INDmoney app.

What are the documents required to start investing in Neumora Therapeutics stocks?

To start investing in Neumora Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neumora Therapeutics Stock (NMRA)?

Today’s highest price of Neumora Therapeutics (NMRA) is $1.45.

Today’s lowest price of Neumora Therapeutics (NMRA) is $1.38.

What is today's market capitalisation of Neumora Therapeutics?

Today's market capitalisation of Neumora Therapeutics NMRA is 228.4M

What is the 52 Week High and Low Range of Neumora Therapeutics Stock (NMRA)?

  • 52 Week High

    $21.00

  • 52 Week Low

    $1.35

What are the historical returns of Neumora Therapeutics (NMRA)?

  • 1 Month Returns

    -25.13%

  • 3 Months Returns

    -86.75%

  • 1 Year Returns

    -92.23%

  • 5 Years Returns

    -91.2%

Who is the Chief Executive Officer (CEO) of Neumora Therapeutics ?

Mr. Jason G. Duncan J.D. is the current Chief Executive Officer (CEO) of Neumora Therapeutics.